Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D02KAU
|
||||
| Former ID |
DCL001220
|
||||
| Drug Name |
PF-03882845
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Diabetic nephropathy [ICD9: 250.4; ICD10:E11.21] | Terminated | [551489] | ||
| Company |
Pfizer
|
||||
| Formula |
C24H22ClN3O2
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Mineralocorticoid receptor | Target Info | Modulator | ||
| KEGG Pathway | Aldosterone-regulated sodium reabsorption | ||||
| PathWhiz Pathway | Kidney Function | ||||
| WikiPathways | ACE Inhibitor Pathway | ||||
| References | |||||